Brii Biosciences Limited

HKEX:2137.HK

1.09 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019
Operating Activities:
Net Income -184.37-489.781-4,191.084-1,283.51-521.028
Depreciation & Amortization 15.67417.03217.26214.2097.493
Deferred Income Tax 00-44.79515.019-5.298
Stock Based Compensation 64.22377.92879.3729.48323.381
Change In Working Capital -120.733-76.994-333.742471.4525.631
Accounts Receivables 00000
Inventory 00000
Accounts Payables 00000
Other Working Capital -33.144-76.994-333.742471.4525.631
Other Non Cash Items -107.529-24.4643,593.532349.633402.545
Operating Cash Flow -594.014-496.279-879.457-403.716-67.276
Investing Activities:
Investments In Property Plant And Equipment -49.608-139.292-1.0290-24.147
Acquisitions Net 56.02801.62300.143
Purchases Of Investments -3,487.006-2,101.905-499.647-196.228-71.555
Sales Maturities Of Investments 3,268.132774.81320.107153.6985.095
Other Investing Activites 1.14633.2163.19-1.12-2.317
Investing Cash Flow -104.35-1,433.168-475.756-43.65-92.781
Financing Activities:
Debt Repayment -9.5-8.96-9.745-6.786-0.2
Common Stock Issued 0.1797.4472,325.2290.1440
Common Stock Repurchased -1.162-0.678000
Dividends Paid 00000
Other Financing Activities -0.3158.109914.65663.643518.547
Financing Cash Flow -10.977-3.0423,230.134657.001518.347
Other Information:
Effect Of Forex Changes On Cash 8.419267.968-54.793-55.0290.95
Net Change In Cash -700.922-1,664.5211,820.128154.606359.24
Cash At End Of Period 489.651,190.5722,855.0931,034.965880.359